logo
Select company
Select metric
51.45%Cash to Assets Ratio
VS
Market
92
Sector
74
Industry
84
History
38
$ 1.57Close
$ 1.51 - $ 9.22 52-Week Range
Ticker Information

Ticker

LUNG

Company Name

PULMONX CORP

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

PULMONX CORP - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LUNG - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 147.19M$ 75.72M51.45%
3/31/2025$ 150.74M$ 74.81M49.63%
12/31/2024$ 162.85M$ 71.16M43.7%
9/30/2024$ 167.4M$ 63.57M37.97%
6/30/2024$ 172.63M$ 63.72M36.91%
3/31/2024$ 164.58M$ 70.39M42.77%
12/31/2023$ 177.78M$ 83.78M47.13%
9/30/2023$ 185.02M$ 95.18M51.44%
6/30/2023$ 193.11M$ 102.05M52.84%
3/31/2023$ 201.27M$ 110.64M54.97%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PULMONX CORP's latest trailing twelve months (TTM) Cash to Assets stands at 56.2%.
  • Over the past 5 years, PULMONX CORP's average Cash to Assets has been 56.91%.
  • The median Cash to Assets for PULMONX CORP during this period was 53.91%
  • PULMONX CORP reached its highest Cash to Assets over the past 5 years at 87.9%.
  • The lowest Cash to Assets recorded by PULMONX CORP in the same timeframe 36.91%

PULMONX CORP's Cash to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash to Assets Benchmarks
CompanyCash to Assets
TELA : TELA BIO INC 52.18%MYO : MYOMO INC 37.79%APYX : APYX MEDICAL CORP 50.36%XTNT : XTANT MEDICAL HOLDINGS INC 6.8%BDSX : BIODESIX INC 23.62%SRTS : SENSUS HEALTHCARE INC 37.66%CTSO : CYTOSORBENTS CORP 24.43%STRO : SUTRO BIOPHARMA INC 24.73%ANIK : ANIKA THERAPEUTICS INC 28.33%MDAI : SPECTRAL AI INC 65.74%

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for PULMONX CORP is calculated as follows: CashnEq [ $ 40.04M ] / Assets [ $ 71.24M ]
(=) Cash to Assets [ 56.2% ]

LUNG - Cash to Assets Ratio, Last 5 years

36.91%

Minimum

Jun 30, 2024

87.9%

Maximum

Dec 31, 2020

56.91%

Average

53.91%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.78% with a standard deviation of 9.53%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.94K
min0%
max40.76%
average9.78%
median6.42%
std9.53%